Radiologist takes over at NIBIB
The imaging community had more to cheer May 7 when the NIH announced the appointment of Dr. Roderic I. Pettigrew as the first permanent director of the National Institute of Biomedical Imaging and Bioengineering. Pettigrew's background in radiology and
The imaging community had more to cheer May 7 when the NIH announced the appointment of Dr. Roderic I. Pettigrew as the first permanent director of the National Institute of Biomedical Imaging and Bioengineering. Pettigrew's background in radiology and engineering makes him an ideal candidate for this NIH division, which addresses a wide range of biomedical technologies. Currently the director of Emory University's Center for MR Research, Pettigrew holds a doctorate from the Massachusetts Institute of Technology's department of nuclear engineering in applied radiation physics. He is also the immediate past chair of the diagnostic imaging study section at the Center for Scientific Review at NIH--the section that reviews grant applications to develop and evaluate new imaging technology, including instrumentation and software for producing, evaluating, storing, and transmitting images.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
